Jane Starczynski

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Testing for t(3;8) in MYC/BCL6-rearranged large B-cell lymphoma identifies a high-risk subgroup with inferior survival.

Testing for t(3;8) in MYC/BCL6-rearranged large B-cell lymphoma identifies a high-risk subgroup with inferior survival.

Journal: Blood
Published: February 12, 2024

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.

Journal: Cancers
Published: November 01, 2022

UK recommendations for HER2 assessment in breast cancer: an update.

UK recommendations for HER2 assessment in breast cancer: an update.

Journal: Journal of clinical pathology
Published: October 13, 2022

The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer.

The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer.

Journal: Histopathology
Published: April 07, 2022

In situ follicular neoplasia with translocation of BCL6 - a new variant with different immunohistochemical properties.

In situ follicular neoplasia with translocation of BCL6 - a new variant with different immunohistochemical properties.

Journal: British journal of haematology
Published: March 02, 2021

Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.

Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.

Journal: Histopathology
Published: December 18, 2018

ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen.

ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 17, 2016

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.

Journal: NPJ breast cancer
Published: December 23, 2015

TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial.

TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial.

Journal: British journal of cancer
Published: June 16, 2015

FKBPL: a marker of good prognosis in breast cancer.

FKBPL: a marker of good prognosis in breast cancer.

Journal: Oncotarget
Published: January 27, 2015

Updated UK Recommendations for HER2 assessment in breast cancer.

Updated UK Recommendations for HER2 assessment in breast cancer.

Journal: Journal of clinical pathology
Published: December 10, 2014

An international study to increase concordance in Ki67 scoring.

An international study to increase concordance in Ki67 scoring.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 14, 2014
Showing 1-12 of 17

Last Updated: 09/26/2026